Does CARFILZOMIB Cause Therapy non-responder? 244 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 244 reports of Therapy non-responder have been filed in association with CARFILZOMIB (KYPROLIS). This represents 1.1% of all adverse event reports for CARFILZOMIB.
244
Reports of Therapy non-responder with CARFILZOMIB
1.1%
of all CARFILZOMIB reports
111
Deaths
21
Hospitalizations
How Dangerous Is Therapy non-responder From CARFILZOMIB?
Of the 244 reports, 111 (45.5%) resulted in death, 21 (8.6%) required hospitalization, and 17 (7.0%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 244 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which CARFILZOMIB Alternatives Have Lower Therapy non-responder Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL